pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
CBP-1019
Breast Cancer
Coherent Biopharma
0
catalysts
Phase 2
CBP-501
Pancreatic Cancer
CanBas Co Ltd
0
catalysts
Preclinical
CBP/p300 Inhibitors
Central Nervous System (CNS) Cancer
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
CBX-12
Colorectal Cancer
Cybrexa Inc
← prev
page 14 of 62
next →
131
Pain
89
Neurology
1
0
catalysts
Preclinical
CC-2401
Solid Tumor
CytoCan Corp
0
catalysts
Preclinical
CC-2402
Solid Tumor
CytoCan Corp
0
catalysts
Phase 1
CCAR-066
Diffuse Large B-Cell Lymphoma
Janssen Biotech Inc
0
catalysts
Phase 1
CD38-SADA
B-Cell Non-Hodgkin Lymphoma
Y-mAbs Therapeutics Inc
0
catalysts
Preclinical
CDKN2A Program
Pancreatic Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 1
CDR-404
Head And Neck Squamous Cell Carcinoma (HNSC)
CDR-Life Inc
0
catalysts
Preclinical
CDX Program
Refractory Acute Myeloid Leukemia
HemoGenyx Pharmaceuticals Plc
0
catalysts
Phase 2
CEP-11981
Pancreatic Cancer
Vascular endothelial growth factor receptor
Angiopoietin-1 receptor
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
0
catalysts
Phase 2
CER-1236
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$CERO
CERO THERAPEUTICS HOLDINGS, INC.
0
catalysts
Phase 2
CFI-402411
Anal Cancer
Treadwell Therapeutics Inc
0
catalysts
Preclinical
CG-923308
Breast Cancer
$GYRE
GYRE THERAPEUTICS, INC.
0
catalysts
Preclinical
CGT-1263
Unspecified Cancer
$COGT
Cogent Biosciences, Inc.
0
catalysts
Phase 1
CHECKVacc
Triple-Negative Breast Cancer (TNBC)
Imugene Ltd
0
catalysts
Phase 1
CHM-0201
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Chimeric Therapeutics Ltd
0
catalysts
Phase 2
CHM-2101
Colon Cancer
Chimeric Therapeutics Ltd
0
catalysts
Phase 2
CHOH-01
B-Cell Non-Hodgkin Lymphoma
CHO Pharma Inc
0
catalysts
Preclinical
CHT-103
Hematological Tumor
Nanjing Miracle Biotechnology Co Ltd
0
catalysts
Preclinical
CHT-104
Hematological Tumor
Nanjing Miracle Biotechnology Co Ltd
0
catalysts
Preclinical
CHT-105
Autoimmune Disorders
Nanjing Miracle Biotechnology Co Ltd
0
catalysts
Preclinical
CIB-201
Renal Cell Carcinoma
Cellinfinity Bio Inc
0
catalysts
Phase 1
CID-078
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Circle Pharma Inc
0
catalysts
Phase 1
CK-0801
Myelodysplastic Syndrome (Preleukemia)
Cellenkos Inc
0
catalysts
Preclinical
CL-04177
Hematological Tumor
Cleara Biotech BV
0
catalysts
Preclinical
CL-04183
Metastatic Colorectal Cancer
Cleara Biotech BV
0
catalysts
Phase 1
CLBR-001
B-Cell Chronic Lymphocytic Leukemia
California Institute for Biomedical Research
0
catalysts
Phase 1
CLD-101
Anaplastic Astrocytoma
$CLDI
Calidi Biotherapeutics, Inc.
0
catalysts
